However, a Phase I clinical involving monotherapy with 24-h intravenous PX-12 for treating advanced gastrointestinal cancer, while completed, showed no clinical activity but exhibited an atypical toxicity profile [229]
As of February 2026 , BPC-157 returned to Category 1 compounding status meaning licensed 503A and 503B compounding pharmacies can legally prepare it under physician prescription
The performance of the cyanidation conversion, which is highly relevant to the obtained total B12 contents, however, was generally neglected during the validation and further applications of the methods
Khawar IA, Kim JH, Kuh H-J (2015) Improving drug delivery to solid tumors: priming the tumor microenvironment
Cell Culture and Treatment 3.2
Effect of composite chitosan/sodium alginate gel coatings on the quality of fresh-cut purple-flesh sweet potato